The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Pharmaceutical giant AstraZeneca admitted in court this week that its COVID-19 vaccine can cause a rare but deadly blood-clotting condition that has become the central focus of a class-action lawsuit ...

CHICAGO (Reuters) - Scientists are exploring several possibilities that might explain at least 18 reports of extremely rare blood clots in the brain that occurred in individuals in the days and weeks ...

LONDON — Denmark, Norway and Iceland announced Thursday they will temporarily suspend the use of the coronavirus vaccine developed by AstraZeneca and the University of Oxford. The Danish Health ...

Add Yahoo as a preferred source to see more of our stories on Google. Covishield was developed by the British-Swedish company in collaboration with Oxford University, UK, and produced by the Serum ...

Use of the AstraZeneca COVID-19 vaccine was suspended again Tuesday in Germany for people under 60 years old after a series of patients reported experiencing blood clots. Authorities say 31 people — ...

ZURICH (Reuters) - U.S. regulators have recommended pausing the use of Johnson & Johnson's COVID-19 vaccine as they investigate rare blood clotting in six women, including one who died. J&J also said ...

The European Union’s drug regulator said Wednesday that it found a "possible link" between the AstraZeneca coronavirus vaccine and a rare clotting disorder but recommended that vaccinations continue ...

Ireland suspended use of the COVID-19 vaccine by Oxford-AstraZeneca on Sunday, citing reports of unusual blood clotting problems among people who recently received shots in Norway. The decision ...

LONDON — The world awaits a decision from Europe’s top medical agency, the European Medicines Agency (EMA), on its investigation into whether there is any evidence to show the AstraZeneca coronavirus ...